Cargando…

Predictive clinical parameters for the response of nivolumab in pretreated advanced non-small-cell lung cancer

BACKGROUND: Nivolumab offers a superior survival benefit over docetaxel in patients with advanced, previously treated non-small-cell lung cancer (NSCLC). An association between programmed cell death ligand-1 (PD-L1) expression and the efficacy of nivolumab has been reported in many studies. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oya, Yuko, Yoshida, Tatsuya, Kuroda, Hiroaki, Mikubo, Masashi, Kondo, Chiaki, Shimizu, Junichi, Horio, Yoshitsugu, Sakao, Yukinori, Hida, Toyoaki, Yatabe, Yasushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732716/ https://www.ncbi.nlm.nih.gov/pubmed/29262550 http://dx.doi.org/10.18632/oncotarget.21602

Ejemplares similares

Successful salvage surgery following multimodal therapy in a patient who harboured ALK‐rearranged advanced lung adenocarcinoma with multiple organ metastases
por: Horio, Yoshitsugu, et al.
Publicado: (2019)

Importance of avoiding surgery delays after initial discovery of suspected non-small-cell lung cancer in clinical stage IA patients
por: Kuroda, Hiroaki, et al.
Publicado: (2018)

Drug-Induced Liver Injury in a Patient with Nonsmall Cell Lung Cancer after the Self-Administration of Fenbendazole Based on Social Media Information
por: Yamaguchi, Teppei, et al.
Publicado: (2021)

Higher frequency of occult lymph node metastasis in clinical N0 pulmonary adenocarcinoma with ALK rearrangement
por: Seto, Katsutoshi, et al.
Publicado: (2018)

Anaplastic lymphoma kinase gene rearrangements in patients with advanced-stage non-small-cell lung cancer: CT characteristics and response to chemotherapy
por: Park, Jangchul, et al.
Publicado: (2014)

Pre-existing interstitial lung disease is associated with onset of nivolumab-induced pneumonitis in patients with solid tumors: a retrospective analysis
por: Yamaguchi, Teppei, et al.
Publicado: (2021)

Successful bronchial arterial infusion chemotherapy combined with radiotherapy for an endobronchial metastasis after resection of small cell lung cancer
por: Horio, Yoshitsugu, et al.
Publicado: (2021)

Prognostic significance of combined radiologic imaging modalities for prognosis of clinical IA adenocarcinomas
por: Kuroda, Hiroaki, et al.
Publicado: (2017)

Spontaneous regression of lung squamous cell carcinoma with synchronous mediastinal progression: A case report
por: Matsui, Takuya, et al.
Publicado: (2018)

Radiological imaging and pathological findings of small lung adenocarcinoma: a narrative review
por: Sakao, Yukinori, et al.
Publicado: (2021)

Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non‐small cell lung cancer
por: Kagawa, Yusuke, et al.
Publicado: (2020)

Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement
por: Oya, Yuko, et al.
Publicado: (2020)

Targeted RNA sequencing with touch imprint cytology samples for non‐small cell lung cancer patients
por: Seto, Katsutoshi, et al.
Publicado: (2020)

Serum ProGRP and NSE levels predicting small cell lung cancer transformation in a patient with ALK rearrangement-positive non-small cell lung cancer: A case report
por: Oya, Yuko, et al.
Publicado: (2018)

Risk factors for pneumonitis in patients with non‐small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective analysis
por: Yamaguchi, Teppei, et al.
Publicado: (2022)

Different Response to Nivolumab in a Patient with Synchronous Double Primary Carcinomas of Hypopharyngeal Cancer and Non-Small-Cell Lung Cancer
por: Yamaguchi, Teppei, et al.
Publicado: (2017)

A retrospective study on analgesic requirements for thoracoscopic surgery postoperative pain
por: Kuroda, Hiroaki, et al.
Publicado: (2017)

Subsegmental resection preserves regional pulmonary function: A focus on thoracoscopy
por: Kuroda, Hiroaki, et al.
Publicado: (2021)

Nivolumab for the treatment of Japanese patients with advanced metastatic non-small cell lung cancer: a review of clinical trial evidence for efficacy and safety
por: Hida, Toyoaki
Publicado: (2018)

Resection of a ruptured mature cystic teratoma diagnosed two years after the onset of perforation
por: Kuroda, Hiroaki, et al.
Publicado: (2014)

Primary pneumonectomy, pneumonectomy after induction therapy, and salvage pneumonectomy: a comparison of surgical and prognostic outcomes
por: Sakakura, Noriaki, et al.
Publicado: (2020)

Lymph node dissection in the left upper lobe: clinical outcomes and surgical techniques in Japan
por: Kuroda, Hiroaki, et al.
Publicado: (2019)

Lymph Node Metastases and Prognosis in Left Upper Division Non-Small Cell Lung Cancers: The Impact of Interlobar Lymph Node Metastasis
por: Kuroda, Hiroaki, et al.
Publicado: (2015)

Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma
por: Park, Jangchul, et al.
Publicado: (2016)

Life-threatening massive bleeding in the pulmonary trunk adjacent to the right ventricular outflow tract during the resection of a large mediastinal germ cell tumor: proposed safety measures in the absence of cardiovascular surgeons: a case report
por: Sakakura, Noriaki, et al.
Publicado: (2021)

GENETIC POLYMORPHISMS OF THE ADENOSINE TRIPHOSPHATE-BINDING CASSETTE TRANSPORTERS(ABCG2, ABCB1) AND GEFITINIB TOXICITY
por: TAMURA, MARIKO, et al.
Publicado: (2012)

Pulmonary infections mimicking malignancy on bronchoscopy: A retrospective single‐center study in Japan
por: Itoh, Naoya, et al.
Publicado: (2020)

Successful IMRT and concurrent chemotherapy for a patient with intrathoracic extensive‐stage small cell lung cancer
por: Horio, Yoshitsugu, et al.
Publicado: (2022)

Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
por: Furune, Satoshi, et al.
Publicado: (2021)

Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
por: Furune, Satoshi, et al.
Publicado: (2021)

Prognostic Awareness and Discussions of Incurability in Patients with Pretreated Non-Small Cell Lung Cancer and Caregivers: A Prospective Cohort Study
por: Hasegawa, Takaaki, et al.
Publicado: (2022)

Duration of nivolumab for pretreated, advanced non–small‐cell lung cancer
por: Geier, Margaux, et al.
Publicado: (2020)

Successful postoperative recovery management after thoracoscopic lobectomy and segmentectomy using an ERAS-based protocol of immediate ice cream intake and early ambulation: a 3-year study
por: Kuroda, Hiroaki, et al.
Publicado: (2019)

Selection of Pathological N0 (pN0) in Clinical IA (cIA) Lung Adenocarcinoma by Imaging Findings of the Main Tumor
por: Kanamoto, Yasuyuki, et al.
Publicado: (2020)

TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth
por: Fujii, Makiko, et al.
Publicado: (2012)

Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study
por: Fujimoto, Nobukazu, et al.
Publicado: (2020)

Prognostic Significance of Tumor Size of Small Lung Adenocarcinomas Evaluated with Mediastinal Window Settings on Computed Tomography
por: Sakao, Yukinori, et al.
Publicado: (2014)

The Significance of the Prognostic Nutritional Index in Patients with Completely Resected Non-Small Cell Lung Cancer
por: Mori, Shunsuke, et al.
Publicado: (2015)

Sarcomatoid malignant pleural mesothelioma treated with nivolumab: A case series
por: Hashimoto, Kentaro, et al.
Publicado: (2022)

First‐line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non‐squamous non‐small cell lung cancer: Updated survival analysis of the ONO‐4538‐52/TASUKI‐52 randomized controlled trial
por: Kim, Hye Ryun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4d1quui422q6u6t8cfbu2hb6ri